DE1937133C3 - Verwendung von Aluminium-, Calcium- oder Magnesiummono-, -di- oder -tristearat - Google Patents

Verwendung von Aluminium-, Calcium- oder Magnesiummono-, -di- oder -tristearat

Info

Publication number
DE1937133C3
DE1937133C3 DE19691937133 DE1937133A DE1937133C3 DE 1937133 C3 DE1937133 C3 DE 1937133C3 DE 19691937133 DE19691937133 DE 19691937133 DE 1937133 A DE1937133 A DE 1937133A DE 1937133 C3 DE1937133 C3 DE 1937133C3
Authority
DE
Germany
Prior art keywords
stearate
aluminum
tablets
distearate
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19691937133
Other languages
German (de)
English (en)
Other versions
DE1937133B2 (de
DE1937133A1 (de
Inventor
James Richard Blaydon- On-Tyne Durham Hargreaves (Grossbritannien)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham SWG Ltd
Original Assignee
Sterling Winthrop Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Group Ltd filed Critical Sterling Winthrop Group Ltd
Publication of DE1937133A1 publication Critical patent/DE1937133A1/de
Publication of DE1937133B2 publication Critical patent/DE1937133B2/de
Application granted granted Critical
Publication of DE1937133C3 publication Critical patent/DE1937133C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE19691937133 1968-07-23 1969-07-22 Verwendung von Aluminium-, Calcium- oder Magnesiummono-, -di- oder -tristearat Expired DE1937133C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3506068A GB1241201A (en) 1968-07-23 1968-07-23 Improvements in or relating to effervescent pharmaceutical compositions

Publications (3)

Publication Number Publication Date
DE1937133A1 DE1937133A1 (de) 1970-10-01
DE1937133B2 DE1937133B2 (de) 1978-07-06
DE1937133C3 true DE1937133C3 (de) 1979-03-15

Family

ID=10373325

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691937133 Expired DE1937133C3 (de) 1968-07-23 1969-07-22 Verwendung von Aluminium-, Calcium- oder Magnesiummono-, -di- oder -tristearat

Country Status (4)

Country Link
DE (1) DE1937133C3 (enrdf_load_stackoverflow)
FR (1) FR2013552A1 (enrdf_load_stackoverflow)
GB (1) GB1241201A (enrdf_load_stackoverflow)
IE (1) IE33495B1 (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1463505A (en) * 1973-11-21 1977-02-02 Nat Res Dev Pharmaceutical compositions
US4265847A (en) 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
GB8820327D0 (en) * 1988-08-26 1988-09-28 May & Baker Ltd New compositions of matter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets

Also Published As

Publication number Publication date
GB1241201A (en) 1971-08-04
DE1937133B2 (de) 1978-07-06
DE1937133A1 (de) 1970-10-01
IE33495L (en) 1970-01-23
IE33495B1 (en) 1974-07-24
FR2013552A1 (enrdf_load_stackoverflow) 1970-04-03

Similar Documents

Publication Publication Date Title
DE68916731T2 (de) Morphin enthaltende Zusammensetzung.
DE2058434C3 (de) Verfahren zum Herstellen von freifließenden, leicht benetzbaren Acetylsalicylsäure enthaltenden Arzneünittelteilchen zur Bereitstellung von brausenden Zubereitungen
DE69110592T2 (de) Pharmazeutische Zubereitung mit verbessertem Geschmack, poröse Partikel enthaltend, und deren Herstellungsmethode.
DE69203471T3 (de) Brausendes Bademittel.
DE69311395T2 (de) Sphäroidische Arzneimittelformulierung
EP0904059A1 (de) Geschmacksverbesserung von arzneimittelwirkstoffen
DE2057239C3 (de) Verfahren zur Herstellung eines stabilen Antischaummittel
DE2020620A1 (de) Traeger fuer das unmittelbare Komprimieren von Tabletten
DE2706660A1 (de) Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung
DE69108022T3 (de) Arzneimittel.
EP0642784A1 (de) Brausemischung mit Alkalisalzen oder Lysinaten saurer, unlöslicher oder schwer löslicher Wirkstoffe
DE68911501T2 (de) Analgetische antacide Brausezusammensetzung mit reduziertem Natriumgehalt.
DE1937133C3 (de) Verwendung von Aluminium-, Calcium- oder Magnesiummono-, -di- oder -tristearat
DE1907546B2 (de) Schnell zerfallende feste dosierungseinheiten
DE3150557C2 (enrdf_load_stackoverflow)
DE69408579T2 (de) Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten
DE1667895C3 (de) Verwendung von Fumarsäure als Gleitmittel bei der Herstellung von wasserlöslichen Brause- oder Arzneimitteltabletten
DE2115116A1 (de) Verbesserte Gleitmittel und Ver fahren zur Herstellung derselben
DE475114C (de) Verfahren zur Herstellung eines Zahnputzmittels
DE2163864A1 (de) Hilfsstoff zur Herstellung von festen geformten Medikamenten
DE2440383A1 (de) Verfahren zur herstellung hilfsstofffreier tabletten
DE938566C (de) Verfahren zur Herstellung von lager- und zerfallfaehigen Arzneimitteltabletten
DE69103724T2 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
DE1617293A1 (de) Verfahren zur Herstellung von geformten Tabletten
DD237114A5 (de) Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee